HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical analyses of perinuclear antineutrophil cytoplasmic antibody associated hypertrophic pachymeningitis].

AbstractOBJECTIVE:
To explore the clinical characteristics, diagnosis, treatment and prognosis of perinuclear antineutrophil cytoplasmic antibody (p-ANCA) associated hypertrophic pachymeningitis.
METHODS:
A retrospective study was performed for 6 inpatients with p-ANCA associated hypertrophic pachymeningitis at our hospital from 2005 to 2012.
RESULTS:
There were 3 males and 3 females with an age range of 52 - 68 years. The main clinical manifestations included headache and multiple cranial neuropathies. Erythrocyte sedimentation rate, C-reactive protein, titer of myeloperoxidase (MPO)-ANCA and protein in cerebrospinal fluid were uniformly elevated in all 6 patients during active phase while cytoplasmic(c)-ANCA was all negative. Head magnetic resonance imaging (MRI) enhancement scan had a high diagnostic sensitivity. Different parts of dura were all thickened and obviously enhanced. Glucocorticoid was uniformly effective. During the follow-up period, 2 cases relapsed and received immunosuppressive agents.
CONCLUSION:
The disease should be considered in elderly patients with headache, cranial nerve injury and positive p-ANCA. And head MRI enhancement scan is helpful for diagnosis.
AuthorsPeng Zhao, Ben-shu Zhang
JournalZhonghua yi xue za zhi (Zhonghua Yi Xue Za Zhi) Vol. 93 Issue 11 Pg. 837-40 (Mar 19 2013) ISSN: 0376-2491 [Print] China
PMID23859390 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antibodies, Antineutrophil Cytoplasmic
Topics
  • Aged
  • Antibodies, Antineutrophil Cytoplasmic (blood)
  • Female
  • Humans
  • Hypertrophy
  • Male
  • Meningitis (blood, diagnosis)
  • Middle Aged
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: